Trials / Completed
CompletedNCT01223742
Oral Acetyl-L-Carnitine Therapy Reduces Fatigue In Hepatic Encephalopathy
ORAL ACETYL-L-CARNITINE THERAPY REDUCES FATIGUE IN HEPATIC ENCEPHALOPATHY
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- —
- Sponsor
- University of Catania · Academic / Other
- Sex
- All
- Age
- 40 Years – 65 Years
- Healthy volunteers
- —
Summary
The aim of this study was to evaluate the effect of exogenous ALC on the both physical and mental fatigue in mild and moderate encephalopatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | ACETYL-L-CARNITINE | 2 g acetylcarnitine taken orally twice a day. |
| DRUG | placebo | placebo twice per day |
Timeline
- Start date
- 2002-06-01
- Completion
- 2006-12-01
- First posted
- 2010-10-19
- Last updated
- 2010-10-19
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT01223742. Inclusion in this directory is not an endorsement.